Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
TTNP > SEC Filings for TTNP > Form 8-K on 27-Sep-2013All Recent SEC Filings

Show all filings for TITAN PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for TITAN PHARMACEUTICALS INC


27-Sep-2013

Other Events, Financial Statements and Exhibits


Item 8.01. Other Events.

On September 26, 2013, Titan Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration ("FDA") has granted the request for a meeting to discuss Probuphine. The meeting is scheduled for November 19, 2013. The FDA has designated the meeting as a Type C meeting and has requested the submission of briefing materials by October 7, 2013.

The press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated herein by reference.



Item 9.01. Financial Statements and Exhibits

(d) Exhibits

99.1 Press release dated September 26, 2013.


  Add TTNP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for TTNP - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.